Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (syncytiotrophoblasts) | 0.10 |
| chemistry Open Targets | a small-molecule pocket | 0.50 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 2 Parkinson's papers of 172 | 0.85 |
| pathways Reactome | 2 pathways; mostly iron and oxidative stress | 0.80 |
No case: the score is under the bar. Receipt 9896
Sealed predictions
- GSTA3 in dopamine neurons, braak+0.23 (p 0.560) → +0.30 (p 0.426)receipt 9903
Swarm cases
receipt 9903: GSTA3 in dopamine neurons, braak
- power
- full sample +0.42 (p 0.086, n 18), 95% CI -0.06 to +0.74. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.41 (p 0.089, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.42 (p 0.082, n 18). could be the mix.
- skeptic
- leave-one-out range +0.36 to +0.51, sign flips 0; without severely affected donors +0.42 (p 0.086, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GSTA3 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts